Baxter's healthy return. Morgan Stanley's Glenn Reicin says the medical products company's prognosis is finally positive.
Stires
David
D
D003132:Commerce / Q000191:economics*; D004864:Equipment and Supplies / Q000191:economics / Q000600:supply & distribution*; D007449:Investments; D014481:United States